Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Pandemic Inspires Impactful Public-Private Partnerships

If COVID-19 has an upside, it’s that the public health crisis has turned fierce competitors unto friendly collaborators and forged unlikely partnerships between groups who tackle problems from a different angle. The biopharmaceutical industry, charitable foundations, academia, and government agencies have come together in unprecedented ways, hoping to break time records in learning how to diagnose, prevent, and treat a new disease.